NIH-funded research Sbir 2 grant

Extended, non-frozen storage for kidney transplants using smart cryoprotectants

Official title: Phase IIB - Greatly Extended Subzero Ischemic Storage of Renal Allografts Using Novel Bio-inspired Next Generation Cryoprotectants

Funded at X-Therma INC. · NIH-11405551 · Data updated 2026-11-12

A new approach uses advanced cryoprotectants to dramatically extend the time kidneys can be kept before transplant, aiming to save more lives by reducing geographic barriers.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionX-Therma INC.
NIH-funded
Lab location1 site (Hercules, UNITED STATES)
Project startAugust 1, 2023
Project endMarch 31, 2028
Funding year2026
Award (this year)$1,100,001
NIH project number2R44DK136396-03
Project IDNIH-11405551 on NIH RePORTER

Who could benefit from this research

Could help

Adults with end-stage kidney disease eligible for kidney transplantation using donor organs.

Less likely to help

Patients not involved in kidney transplantation or where donors are not a consideration may not benefit directly.

What this research studies

This project aims to keep donated kidneys usable for much longer than today’s limits by using novel, bio-inspired cryoprotectants and subzero preservation. It combines chemistry advances with transplant expertise to test the safety and effectiveness of non-frozen storage and assess how well kidneys can be transplanted after extended ischemia times. The work plans to integrate into current surgical workflows and address real-world issues like donor–recipient matching and coordination. The effort seeks to build a robust data set to support longer preservation times and better organ utilization.

Why it matters

Potential benefit: If successful, patients could receive transplants sooner or from a wider geographic area, potentially reducing wait times and improving graft survival.

How similar studies have gone: Previous organ preservation efforts have shown that improved preservation methods can extend viability, but this project aims to substantially extend ischemia tolerance.

Where this research is happening

  • X-Therma INC.
    Hercules, United States
    Active

Researchers

  • Principal investigator: Kline, Mark a — X-Therma INC.
  • Study coordinator: Kline, Mark a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.